We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine... Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market. Show more
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B PR Newswire BURLINGTON, N.C., April 29, 2024...
Labcorp Announces 2024 First Quarter Results PR Newswire BURLINGTON, N.C., April 25, 2024 Updates Full-Year Guidance Results from Continuing Operations for first quarter 2024 versus last...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire BURLINGTON, N.C., April 24, 2024 Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire SAN FRANCISCO, April 24, 2024 – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court...
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw PR Newswire BURLINGTON, N.C., April 15, 2024 Innovative GFAP...
Labcorp Declares Quarterly Dividend PR Newswire BURLINGTON, N.C., April 11, 2024 BURLINGTON, N.C., April 11, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and...
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit PR Newswire BURLINGTON, N.C., April 10, 2024 The first at-home mpox testing kit provides patients with...
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs PR Newswire BURLINGTON, N.C., April...
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research PR Newswire BURLINGTON, N.C., April 5, 2024 Labcorp Plasma Detect is the...
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research PR Newswire BURLINGTON, N.C., April 2, 2024 Researchers...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.24 | 2.15141059468 | 197.08 | 207.535 | 197.01 | 920393 | 201.47591665 | CS |
4 | -9.68 | -4.58767772512 | 211 | 212.685 | 196.11 | 851870 | 203.50181618 | CS |
12 | -21.41 | -9.61253535671 | 222.73 | 229.46 | 196.11 | 811891 | 211.35901115 | CS |
26 | -6.52 | -3.13702848345 | 207.84 | 234.09 | 196.11 | 761619 | 215.27104374 | CS |
52 | -26.65 | -11.6901346668 | 227.97 | 243.3 | 195.01 | 752333 | 213.6844572 | CS |
156 | -66.68 | -24.8805970149 | 268 | 317.17 | 195.01 | 730274 | 242.9155659 | CS |
260 | 35.02 | 21.0583283223 | 166.3 | 317.17 | 98.02 | 739248 | 217.99272764 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions